Format

Send to

Choose Destination
N Engl J Med. 2013 Mar 28;368(13):1169-71. doi: 10.1056/NEJMp1302513. Epub 2013 Mar 13.

Regulatory innovation and drug development for early-stage Alzheimer's disease.

Author information

1
Division of Neurology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
PMID:
23484795
DOI:
10.1056/NEJMp1302513
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center